A total of 621 patients enrolled in the COURAGE ( Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation ) trial with baseline quantitative nuclear single-photon emission computed tomography ( SPECT ) and quantitative coronary angiography were studied .